The Safety and Efficacy of Intrathecal Adenosine in Patients with Chronic Neuropathic Pain
- 1 July 1999
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (1), 136-142
- https://doi.org/10.1213/00000539-199907000-00023
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Intrathecal Adenosine AdministrationAnesthesiology, 1998
- Intrathecal administration of the adenosine A1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central painNeuroscience Letters, 1998
- Adenosine receptor activation suppresses tactile hypersensitivity and potentiates spinal cord stimulation in mononeuropathic ratsNeuroscience Letters, 1997
- Intrathecal and systemic R-phenylisopropyl-adenosine reduces scratching behaviour in a rat mononeuropathy modelNeuroReport, 1996
- Systemic Adenosine Infusion Alleviates Spontaneous and Stimulus Evoked Pain in Patients with Peripheral Neuropathic PainAnesthesia & Analgesia, 1995
- Systemic adenosine infusion: a new treatment modality to alleviate neuropathic painPain, 1995
- Systemic adenosine attenuates touch evoked allodynia induced by mustard oil in humansNeuroReport, 1995
- The Influence of Adenosine, Ketamine, and Morphine on Experimentally Induced Ischemic Pain in Healthy VolunteersAnesthesia & Analgesia, 1994
- Effects of Intrathecal Injection of the Adenosine Receptor Agonists R-Phenylisopropyl-Adenosine and N-Ethylcarboxamide-Adenosine on Nociception and Motor Function in the RatAnesthesia & Analgesia, 1990
- The role of purines in nociceptionNeuroscience, 1989